In a nationwide first, the US Food and Drug Administration (FDA) has authorized the use of ‘Epidiolex’, a marijuana derivative which will be used to treat rare forms of epilepsy. Epidiolex — also known as cannabidiol or CBD — is a highly-purified version of the many psychoactive compounds found in marijuana, and does not result in a high.
This year, the Food and Drug Administration is joining stoners the world over in celebrating 4/20. Continue reading An FDA Panel Just Recommended an Epilepsy Drug Made from Cannabis
You might be familiar with the concept of 3D-printed medical equipment, but you’re going to have to get used to seeing 3D-printed medicine, too. The US Food and Drug Administration has approved its first drug manufactured using 3D printing, Aprecia’s epilepsy-fighting Spritam.